| Methods |
computer generated random table |
| Participants |
150 pregnant women , </= 63 days of amenorrhoea,
confirmed by ultrasound
at the University Hospital Hong Kong
inclusion criteria: good health, willing to use barrier methods for contraception until first menses after termination, haemoglobin level >110g/L
exclusion criteria: significant past or present illness, allergy/contraindication towards study medication, intrauterine device, heavy smoker, breast feeding |
| Interventions |
Mifepristone 200 mg for all women
group A: misoprostol 800mcg/po and misoprostol 400mcg/X2/day/po for day 4‐10
group B: misoprostol 800mcg/pv on day 3 and misoprostol 400mcg/X2/day/po for day 4 ‐10
group C: misoprostol 800mcg/pv on day 3 and placebo tablets on day 4‐10 |
| Outcomes |
complete, incomplete, missed abortion, ongoing pregnancy, blood loss, haemoglobin levels |
| Notes |
no major complications were reported |
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Allocation concealment (selection bias) |
Unclear risk |
B ‐ Unclear |
